Eppendorf continues on course for success
The Asian market and the services segment in particular contributed to this good result. During the reporting year, Eppendorf significantly increased expenses for research and development to €34.8 million (prior year: €31.9 million). In addition, the company expanded its global service and sales presence, among other things through the acquisition of a company in Ireland.
“Once again, we can look back on a good fiscal year. We want to continue developing dynamically and are currently working on a variety of measures to ensure we achieve profitable growth in the future as well,” said Thomas Bachmann, President & Chief Executive Officer of Eppendorf AG. “In addition to carrying out various internal projects, we took the step early this year, for instance, of acquiring a controlling interest in the Dutch company Bio-ITech B.V. after working closely with them last year on device and data networking.”
In 2017, the company will continue to focus on product and application development as well as on the ongoing expansion of its sales, development and production sites.
Most read news
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.